The Treatment of Hallucinations in Schizophrenia Spectrum Disorders [PDF]
, 2012 This article reviews the treatment of hallucinations in schizophrenia. The first treatment option for hallucinations in schizophrenia is antipsychotic medication, which can induce a rapid decrease in severity.
Agid +46 more
core +4 more sources
Rabbit syndrome: update on aetiology and management for pharmacists, psychiatrists and dentists [PDF]
, 2019 Rabbit syndrome (RS) is an involuntary movement disorder, characterized by fast and fine movements of oral and masticatory muscles along the mouth vertical axis in the absence of tongue involvement.
Girgis, Eriny +2 more
core +1 more source
Trends in resource utilization for new‐onset psychosis hospitalizations at children's hospitals
Journal of Hospital Medicine, Volume 20, Issue 7, Page 710-726, July 2025.Abstract Background Children with new‐onset psychosis often require hospitalization for medical evaluation. Objectives The goal of this study was to assess variations in the management of children with new‐onset psychosis and characterize trends in resource utilization.
Ankita Gupta +8 more
wiley +1 more source
Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia [PDF]
, 2013 Cognitive impairments are considered to largely affect functional outcome in patients with schizophrenia, other psychotic illnesses, or mood disorders. Specifically, there is much attention to the role of psychotropic compounds acting on serotonin (5-HT)
Takashi Uehara +2 more
core +2 more sources
Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry:A Cross-sectional Study of Common Conditions in the United States [PDF]
, 2013 BACKGROUND: Financial ties between health professionals and industry may unduly influence professional judgments and some researchers have suggested that widening disease definitions may be one driver of over-diagnosis, bringing potentially unnecessary ...
Bero, Lisa +5 more
core +4 more sources
, 2008 Antidepressant monotherapy is a first-line treatment for depression; however, not all sufferers will adequately respond to treatment. When treating a patient with treatment-resistant depression, the clinician needs to consider all factors which may ...
Beasley +47 more
core +1 more source
The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial [PDF]
, 2013 BACKGROUND: Schizophrenia is a highly heterogeneous disorder with positive and negative symptoms being characteristic manifestations of the disease. While these two symptom domains are usually construed as distinct and orthogonal, little is known about ...
Ascher-Svanum, H +6 more
core +2 more sources
Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior [PDF]
, 2014 Background: Several second generation antipsychotics (SGAs) received FDA approval for bipolar disorder in the 2000s. Although efficacious, they have been costly and may cause significant side effects.
Bajor, Laura +7 more
core +2 more sources
Integrating Pharmacotherapy and Psychotherapy for Paediatric Bipolar Disorder: Translating Science to Service [PDF]
, 2005 Objective: For comprehensive management of paediatric bipolar disorder (PBD), it is imperative to combine psychopharmacotherapy with specific psychotherapy.
Mani N., Pavuluri, Smita, Kampani
core
Manic/hypomanic symptoms induced by aripiprazole [PDF]
, 2010 Aripiprazol é um antipsicótico atípico (AAt) frequentemente indicado para o tratamento agudo da mania, assim como para quadros mistos de transtorno bipolar (TB) tipo I e para o tratamento de manutenção do TB tipo I.
MORENO, Ricardo Alberto +2 more
core +3 more sources